anti- Caspase 8 antibodyСпецификацияClonality | monoclonal | Host | Mouse | Specificity | Human | Tested Application | ELISA, IHC, WB,IF,IP | Delivery Time | 2 to 4 working days | Clone ID | 2C2 | Isotype | IgG1 | Form | liquid | Purification | Protein A+G purification | Purity | ≥95% as determined by SDS-PAGE | Uniprot ID | Q14790 | Calculated MW | 50-55 kDa, 25-32 kDa | Ссылка на страницу на сайте производителя | ссылка | Инструкция | PDF | Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.) | Background | Caspase 8, also named as MCH5, MACH, FLICE, and CAP4, belongs to the peptidase C14A family. It may participate in the GZMB apoptotic pathways and functions as an upstream regulator in a-bisabolol-induced apoptosis. Caspase 8 catalyzes an essential intermediate step in the ubiquitination and proteasome-mediated degradation of IRF3(PMID:21816816). It may control diabetic embryopathy-associated apoptosis via Caspase 8 is expressed as nine isoforms by alternative splicing with the molecular mass from 26 kDa to 62 kDa. This antibody can recognize pro-and cleaved-caspase 8. | Immunogen | caspase 8, apoptosis-related cysteine peptidase | Synonyms | Apoptotic cysteine protease, Apoptotic protease Mch 5, Casp 8, CASP8, Caspase 8, Caspase 8/p18, Caspase8, FADD like ICE, FLICE, ICE like apoptotic protease 5, MACH, MCH5 | Recommended dilution | WB: 1:500-1:5000; IP: 1:200-1:2000; IHC: 1:100-1:400; IF: 1:50-1:500 | Immunohistochemistry of paraffin-embedded human liver cancer tissue slide using FNab01294(Caspase 8 Antibody) at dilution of 1:200 heat mediated antigen retrieved with Tris-EDTA buffer(pH9).
| HepG2 cells were subjected to SDS PAGE followed by western blot with FNab01294(CASP8 antibody) at dilution of 1:1000
| | |
Информация для заказаОбласть использования: | Производство: | Fine Biotech | Метод: | Антитела | Объем: | 100µg | Кат. номер: | FNab01294 | Цена (с НДС 20%): | по запросу | В корзину | Наименование: anti- Caspase 8 antibody. Примечание: |
|